4 citations
,
November 2021 in “Journal of the European Academy of Dermatology and Venereology” There might be a skin condition related to COVID-19.
1 citations
,
December 2020 in “Journal of diabetes and endocrine practice” I'm sorry, but I can't provide a summary without the content of the document.
October 2025 in “Brazilian Journal of Veterinary Research and Animal Science” Neotropical porcupines can get co-infected with poxvirus and Toxoplasma gondii.
Cepharanthine and tetrandrine show promise as COVID-19 drugs.
July 2021 in “Clinical Medicine” Sexually transmitted infections and HIV should be considered as possible causes of chronic diarrhea, especially in men who have sex with men.
October 2023 in “Frontiers in Pharmacology” Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.
April 2026 in “Clinical Journal of Gastroenterology” Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.
6 citations
,
April 2022 in “Biomedicines” COVID-19 may harm male fertility by affecting sperm production.
January 2024 in “Pediatria Polska” Long-COVID symptoms in children after MIS-C are similar across different COVID-19 variants, with older age being a key factor.
8 citations
,
August 2022 in “Microorganisms” A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.
6 citations
,
November 2015 in “Equine Veterinary Education” A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.
September 2023 in “Indian Journal of Postgraduate Dermatology” Few healthcare workers had skin reactions after Covid-19 vaccination.
17 citations
,
September 2024 in “The Indian Journal of Medical Research” Long COVID can cause long-lasting symptoms, but vaccination and early treatment can help prevent it.
118 citations
,
November 2024 in “World Journal of Biology Pharmacy and Health Sciences” Pregnant and breastfeeding women should get COVID-19 vaccines for safety and protection.
12 citations
,
December 2016 in “Medical Hypotheses” A vaccine may prevent benign prostatic hyperplasia (BPH).
May 2022 in “Голова и шея.” COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.
March 2024 in “EMBO molecular medicine” Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” COVID-19 may increase hair loss due to stress and inflammation.
65 citations
,
June 2021 in “Frontiers in Pharmacology” Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.
Providing housing and case management reduces hospital visits for chronically ill homeless adults.
16 citations
,
March 2022 in “Journal of Infection” Booster doses of Covaxin improve protection against the Omicron variant.
Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.
4 citations
,
January 2021 in “The Southwest Respiratory and Critical Care Chronicles” Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.
Covid-19 vaccination during pregnancy is safe for mothers and babies.
3 citations
,
January 2014 in “Middle East African Journal of Ophthalmology” A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.
4 citations
,
December 2024 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health conditions.
Cepharanthine could be a strong antiviral against COVID-19.
July 2024 in “Journal of Investigative Dermatology” DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.
7 citations
,
January 2025 in “Journal of Experimental & Clinical Cancer Research” PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.
21 citations
,
August 2002 in “British Journal of Ophthalmology” Intralesional cidofovir may be a viable alternative treatment for SCC.